Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.99
+0.17 (1.73%)
Jun 10, 2026, 3:00 PM EDT - Market open

Phathom Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
204.89175.1155.250.68--
Revenue Growth (YoY)
150.30%216.93%8001.47%---
Cost of Revenue
30.8722.67.970.17--
Gross Profit
174.02152.5147.280.52--
Selling, General & Admin
239.25279.72290.66117.9310162.74
Research & Development
31.3732.7834.0849.971.4472.34
Total Operating Expenses
270.62312.5324.75167.83172.44135.08
Operating Income
-96.6-159.99-277.47-167.31-172.44-135.08
Interest Income
6.147.0415.167.882.130.04
Interest Expense
-65.84-68.12-72.01-41.97-27.31-6.79
Other Non-Operating Income (Expense)
-1-0.19-0.01-0.19-0.11-2.06
Total Non-Operating Income (Expense)
-60.7-61.26-56.86-34.28-25.28-8.8
Pretax Income
-157.3-221.25-334.33-201.59-197.72-143.88
Net Income
-157.3-221.25-334.33-201.59-197.72-143.88
Net Income to Common
-157.3-221.25-334.33-201.59-197.72-143.88
Shares Outstanding (Basic)
757363513937
Shares Outstanding (Diluted)
757363513937
Shares Change (YoY)
13.35%15.42%23.18%31.11%5.72%11.36%
EPS (Basic)
-2.12-3.03-5.29-3.93-5.05-3.89
EPS (Diluted)
-2.12-3.03-5.29-3.93-5.05-3.89
Shares Outstanding
79.4471.4268.5257.9741.4730.51
Free Cash Flow
-97.76-167-266.91-139.21-147.57-148.79
Free Cash Flow Per Share
-1.30-2.29-4.22-2.71-3.77-4.02
Gross Margin
84.93%87.09%85.57%75.51%--
Operating Margin
-47.15%-91.36%-502.18%-24532.60%--
Profit Margin
-76.77%-126.35%-605.09%-29558.90%--
FCF Margin
-47.71%-95.37%-483.07%-20412.60%--
EBITDA
-96.03-159.35-276.67-166.74-171.82-134.56
EBITDA Margin
-46.87%-91.00%-500.75%-24448.20%--
EBIT
-96.6-159.99-277.47-167.31-172.44-135.08
EBIT Margin
-47.15%-91.36%-502.18%-24532.60%--
SEC Filings: 10-K · 10-Q